Atopic Dermatitis and Obesity
Atopic dermatitis, or eczema, is an itchy inflammatory skin condition that is modestly more common in people with obesity, especially children, and tends to be more severe at higher body mass index.
Plain English
Patient-Friendly Explanation
Atopic dermatitis, commonly called eczema, is a chronic inflammatory skin condition. It causes dry, itchy, red patches that come and go, and the itch is often worse at night. Scratching damages the skin barrier and lets more irritants and bacteria in, so the condition tends to feed itself. It usually starts in childhood and, in many people, settles by adulthood, though a substantial number continue to have flares. The link with body weight is real but modest. A pooled analysis of thirty-three studies found that children with obesity were about twenty per cent more likely to have atopic dermatitis than children of normal weight, and that the association was weaker in adults, where it did not reach statistical significance. Being overweight was associated with only a slight increase in risk. The same analysis noted that the evidence does not establish that higher body mass index causes the skin condition, and the relationship may run in both directions, because itchy skin and disturbed sleep can reduce activity. Other work goes further in one direction: in a large German registry of patients with moderate to severe eczema, obesity was linked to more severe disease, and a long-term birth cohort found that children with severe eczema who slept badly had higher body mass index, waist measurement and body fat in young adulthood. There are plausible mechanisms. Fat tissue releases inflammatory signals such as leptin and reduces protective adiponectin, and chronic low-grade inflammation is common to both conditions. Obesity also impairs the skin barrier, increasing water loss and dryness, and in a humid climate like Singapore, sweating and friction in skin folds adds further irritation. Management is the usual skin care - regular emollients, avoiding harsh soaps and fragrances, treating flares promptly with appropriate creams, and anti-inflammatory or biologic treatment for severe disease - together with attention to weight where it is elevated. Patients who lose weight often report that their skin settles, which makes this a useful additional motivator in a weight-management consultation.
Medical
Clinical Definition
Atopic dermatitis (AD) is a chronic, relapsing inflammatory dermatosis characterised by impaired epidermal barrier function, pruritus and a Th2-skewed immune response. A meta-analysis of 33 published studies found an odds ratio for AD of 1.05 (95% CI 0.94 to 1.19) in overweight adults and 1.08 (1.00 to 1.16) in overweight children; for obesity the odds ratio was 1.19 (95% CI 0.95 to 1.49) in adults (1,400,679 participants) and 1.20 (95% CI 1.11 to 1.30) in children (796,514 participants), with approximately a 2% increase in odds per 1 kg/m2 higher body mass index. The same analysis examined causality and did not establish that body mass index causes AD, so the association is described as observational and probably bidirectional. Prospective registry data (TREATgermany) show obesity associated with greater disease severity in moderate to severe AD, and a population-based birth cohort followed to age 24 found that severe childhood AD with sleep disturbance was associated with higher body mass index, waist circumference, body fat percentage and blood pressure in young adulthood, with sex differences. Proposed mechanisms include adipokine imbalance (increased leptin, reduced adiponectin in both obesity and AD), interleukin-6 and tumour necrosis factor alpha release from hypertrophic adipocytes, impaired epidermal barrier with increased transepidermal water loss and skin dryness, increased sweating with heat and friction in intertriginous areas, and altered skin microbiome colonisation, particularly Staphylococcus aureus, in skin folds. Management follows standard AD care - emollients, topical corticosteroids or calcineurin inhibitors, and systemic or biologic therapy (for example dupilumab or Janus kinase inhibitors) for severe disease - with weight management as an adjunct. Reports indicate that intentional weight reduction improves AD symptoms and severity, which is plausible through reduction in adipokine-driven inflammation, and severity should be documented objectively (EASI or SCORAD) if weight is being tracked as an intervention.
Key Insight
Why It Matters
Skin symptoms are a powerful motivator for patients. Many people with eczema who reduce their weight notice less itching, fewer flares and improved sleep, and reporting that possibility honestly - as a likely benefit rather than a certainty - supports adherence. The evidence should be described accurately: the association with obesity is modest, strongest and most consistent in children, and severity rather than prevalence seems to be the clearest link. In practice, weight management sits alongside good dermatological care for eczema; it does not replace it, and the skin needs treating on its own terms.
Sources
Reviewed against standard medical references.
Medically reviewed by
Family Physician & Registered Acupuncturist, Accord Medical Clinic. MBBS (NUS), Graduate Diploma in Family Medicine (NUS), Graduate Diploma in Acupuncture (Singapore College of TCM).
Last reviewed: October 2026
This page is general health education, not medical advice. Whether any treatment is appropriate for you is a decision made in consultation after assessment.
